The dolutegravir story: A Decade of Access

Join us on Tuesday 28 May for a special event on the sidelines of the World Health Assembly as we celebrate ten years of access to dolutegravir (DTG).   

Over the last year, the Medicines Patent Pool (MPP) has met with communities taking generic DTG  regimens or working with people who do. Our film is a collection of testimonials on the impact of DTG on lives, but also personal accounts of living with HIV in 2024. The film contains voices of men, women, children, and transgender people and covers issues that are still very much alive, such as adherence, stigma and mental health.

Since the signing of licensing agreements between ViiV Healthcare and MPP, with the support of Unitaid and numerous public health partners, over 1 billion packs of generic DTG have been distributed to 24 million adults and children living with HIV in 128 low- and middle-income countries. This has resulted in over 90% of individuals on antiretroviral treatment in these countries receiving DTG-based regimens. After the screening, a panel will discuss lessons learned along this journey and their relevance to future treatment and prevention therapies.

Secure your ticket now. 
Cinema seats are limited!

When: Tuesday 28 May – 18.30
Where: Cinema Nord-Sud, Rue de Servette 78, Geneva
Transport: Available between 17.30-18.30 leaving Palais de Nations – Pregny Gate
Reception:  from 20.15 at restaurant Les Lauriers 7, rue de Veyrassat, just around the corner from the cinema